Tumor vascular microenvironment determines responsiveness to photodynamic therapy.

The efficacy of photodynamic therapy (PDT) depends upon the delivery of both photosensitizing drug and oxygen. In this study, we hypothesized that local vascular microenvironment is a determinant of tumor response to PDT. Tumor vascularization and its basement membrane (collagen) were studied as a function of supplementation with basement membrane matrix (Matrigel) at the time of tumor cell inoculation. Effects on vascular composition with consequences to tumor hypoxia, photosensitizer uptake, and PDT response were measured. Matrigel-supplemented tumors developed more normalized vasculature, composed of smaller and more uniformly spaced blood vessels than their unsupplemented counterparts, but these changes did not affect tumor oxygenation or PDT-mediated direct cytotoxicity. However, PDT-induced vascular damage increased in Matrigel-supplemented tumors, following an affinity of the photosensitizer Photofrin for collagen-containing vascular basement membrane coupled with increased collagen content in these tumors. The more highly collagenated tumors showed more vascular congestion and ischemia after PDT, along with a higher probability of curative outcome that was collagen dependent. In the presence of photosensitizer-collagen localization, PDT effects on collagen were evidenced by a decrease in its association with vessels. Together, our findings show that photosensitizer localization to collagen increases vascular damage and improves treatment efficacy in tumors with greater collagen content. The vascular basement membrane is thus identified to be a determinant of therapeutic outcome in PDT of tumors.

[1]  B. Dadvand,et al.  Injectable Soft-Tissue Fillers: Clinical Overview , 2006, Plastic and reconstructive surgery.

[2]  R. G. Statius van Eps,et al.  Platelet Adhesion to Photodynamic Therapy–treated Extracellular Matrix Proteins¶ , 2002 .

[3]  S. Ametamey,et al.  Ionizing Radiation Antagonizes Tumor Hypoxia Induced by Antiangiogenic Treatment , 2006, Clinical Cancer Research.

[4]  Arjun G. Yodh,et al.  Noninvasive Monitoring of Murine Tumor Blood Flow During and After Photodynamic Therapy Provides Early Assessment of Therapeutic Efficacy , 2005, Clinical Cancer Research.

[5]  E. Hoving,et al.  Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma? , 2010, Neuropathology and applied neurobiology.

[6]  Candace S. Johnson,et al.  A new immunocompetent murine model for oral cancer. , 1997, Archives of otolaryngology--head & neck surgery.

[7]  Arjun G. Yodh,et al.  Epidermal Growth Factor Receptor Inhibition Modulates the Microenvironment by Vascular Normalization to Improve Chemotherapy and Radiotherapy Efficacy , 2009, PloS one.

[8]  Junmei Chen,et al.  Interactions of Platelets with Subendothelium and Endothelium , 2005, Microcirculation.

[9]  G. Hamann,et al.  Microvascular damage following experimental sinus-vein thrombosis in rats , 2003, Acta Neuropathologica.

[10]  U. Igbaseimokumo.  Quantification of in vivo Photofrin uptake by human pituitary adenoma tissue. , 2004, Journal of neurosurgery.

[11]  D. Jayne,et al.  Extracellular matrix proteins and chemoradiotherapy: α5β1 integrin as a predictive marker in rectal cancer , 2002 .

[12]  R. Jain,et al.  Human tumor xenografts recurring after radiotherapy are more sensitive to anti-vascular endothelial growth factor receptor-2 treatment than treatment-naive tumors. , 2007, Cancer research.

[13]  F. Hetzel,et al.  Hyperoxygenation Enhances the Tumor Cell Killing of Photofrin-mediated Photodynamic Therapy¶ , 2003, Photochemistry and photobiology.

[14]  R. G. Statius van Eps,et al.  Platelet Adhesion to Photodynamic Therapy–treated Extracellular Matrix Proteins ¶ , 2002, Photochemistry and photobiology.

[15]  S. Hahn,et al.  Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ]. , 2000, Cancer research.

[16]  H. Kleinman,et al.  Matrigel: basement membrane matrix with biological activity. , 2005, Seminars in cancer biology.

[17]  C. Koch,et al.  Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen. , 2002, Cancer research.

[18]  T. Dougherty,et al.  An Assay for the Quantitation of Photofrin in Tissues and Fluids , 1997, Photochemistry and photobiology.

[19]  D. McDonald,et al.  Cellular abnormalities of blood vessels as targets in cancer. , 2005, Current opinion in genetics & development.

[20]  B. Pogue,et al.  Tumor Vascular Area Correlates with Photosensitizer Uptake: Analysis of Verteporfin Microvascular Delivery in the Dunning Rat Prostate Tumor , 2006, Photochemistry and photobiology.

[21]  Dai Fukumura,et al.  Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy. , 2002, Cancer research.

[22]  Daniel B. Shin,et al.  Photofrin Uptake in the Tumor and Normal Tissues of Patients Receiving Intraperitoneal Photodynamic Therapy , 2006, Clinical Cancer Research.

[23]  Tayyaba Hasan,et al.  Pretreatment photosensitizer dosimetry reduces variation in tumor response. , 2006, International journal of radiation oncology, biology, physics.

[24]  Rakesh K. Jain,et al.  Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors , 2004, Cancer Research.

[25]  Ronald G Blasberg,et al.  Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors. , 2010, Cancer research.

[26]  Raghu Kalluri,et al.  Structure and Function of Basement Membranes , 2007, Experimental biology and medicine.

[27]  T. Hasan,et al.  Mechanisms of resistance to photodynamic therapy. , 2011, Current medicinal chemistry.

[28]  Lei Xu,et al.  Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. , 2004, Cancer cell.

[29]  D. Jayne,et al.  Extracellular matrix proteins and chemoradiotherapy: alpha5beta1 integrin as a predictive marker in rectal cancer. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[30]  Rakesh K. Jain,et al.  Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases , 2011, Nature Reviews Drug Discovery.

[31]  N. Pimstone,et al.  The interaction of tumour‐localizing porphyrins with collagen, elastin, gelatin, fibrin and fibrinogen , 1985, Cell biochemistry and function.

[32]  Tayyaba Hasan,et al.  Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  Timothy C Zhu,et al.  Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy , 2009, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[34]  B. Pogue,et al.  Analysis of Effective Molecular Diffusion Rates for Verteporfin in Subcutaneous Versus Orthotopic Dunning Prostate Tumors¶ , 2004, Photochemistry and photobiology.

[35]  Q. Peng,et al.  Effects of Photodynamic Therapy on Tumor Stroma , 2004, Ultrastructural pathology.

[36]  D. McDonald,et al.  Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. , 2003, The American journal of pathology.

[37]  Shingo Matsumoto,et al.  Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia. , 2011, Cancer research.

[38]  E. Bernhard,et al.  Modulating tumor vasculature through signaling inhibition to improve cytotoxic therapy. , 2010, Cancer research.

[39]  D A Musser,et al.  The interaction of tumor localizing porphyrins with collagen and elastin. , 1982, Research communications in chemical pathology and pharmacology.

[40]  Lei Xu,et al.  Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.

[41]  Michael J. Emanuele,et al.  Hypoxia and Photofrin Uptake in the Intraperitoneal Carcinomatosis and Sarcomatosis of Photodynamic Therapy Patients , 2004, Clinical Cancer Research.

[42]  H. Dvorak,et al.  Why are tumour blood vessels abnormal and why is it important to know? , 2009, British Journal of Cancer.

[43]  Y. Hung,et al.  Clinicopathologic significance of tumor cell-lined vessel and microenvironment in oral squamous cell carcinoma. , 2008, Oral oncology.

[44]  T. Wieman,et al.  The Effects of Thrombocytopenia on Vessel Stasis and Macromolecular Leakage after Photodynamic Therapy Using Photofrin , 1997, Photochemistry and photobiology.

[45]  M. Dewhirst,et al.  Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts , 2007, British Journal of Cancer.

[46]  J. Gray,et al.  A new mouse tumor model system (RIF-1) for comparison of end-point studies. , 1980, Journal of the National Cancer Institute.

[47]  Q. Peng,et al.  Localization of fluorescent photofrin ii and aluminum phthalocyanine tetrasulfonate in transplanted human malignant tumor LOX and normal tissues of nude mice using highly light‐sensitive video intensification microscopy , 1990, International journal of cancer.

[48]  Andrew H. Kaye,et al.  Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome , 2004, Journal of Clinical Neuroscience.

[49]  T. Merchant,et al.  Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation. , 2010, International journal of radiation oncology, biology, physics.

[50]  Guoqiang Yu,et al.  Increasing Damage to Tumor Blood Vessels during Motexafin Lutetium-PDT through Use of Low Fluence Rate , 2010, Radiation research.

[51]  M. Dewhirst,et al.  Effect of Pazopanib on Tumor Microenvironment and Liposome Delivery , 2010, Molecular Cancer Therapeutics.

[52]  M. C. Pazos,et al.  Effect of photodynamic therapy on the extracellular matrix and associated components. , 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.